Antibody Diagnostics

ModiQuest founders developed the first diagnostics test for rheumatoid arthritis, marketed worldwide and included in the American College of Rheumatology (ACR) diagnostics criteria.

Antibody Therapeutics

ModiQuest's pipeline of preclinical candidates includes monoclonal and recombinant antibody therapeutics for prevention and treatment of established rheumatoid arthritis.

About ModiQuest

Experts in monoclonal and recombinant antibody generation for autoimmune and oncology, with high throughput hybridoma and phage display technology.

Latest News

• ModiQuest to attend PEGS 2013 conference in Boston and to present posters on its novel programs for Rheumatoid Arthritis and Oncology
• ModiQuest Announces Publication of its Novel Anti-Citrullinated Protein Antibodies for Rheumatoid Arthritis
• ModiQuest at Bio-Europe Spring in Barcelona
• ModiQuest Research on Dutch national television!